2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-106350
    Cefpimizole 84880-03-5 98%
    Cefpimizole (U-63196E) is a broad-spectrum cephalosporin antibiotic. Cefpimizole inhibits many Ampicillin (HY-B0522)-resistant bacteria, and is active against gram-negative species. Cefpimizole augments phagocytosis of macrophages and neutrophils.
    Cefpimizole
  • HY-106352
    BMS 605339 630417-82-2 98%
    BMS 605339 is a linear tetra-peptide α-ketoamide inhibitor of HCV NS3 protease. BMS 605339 can be used in research related to hepatitis C (HCV infection).
    BMS 605339
  • HY-106472
    Tioxaprofen 40198-53-6 98%
    Tioxaprofen is a new anti-mycotic drug against Trichophyton mentagrophytes and T. rubrum, and is a potent uncoupling agent of mitochondrial respiration.
    Tioxaprofen
  • HY-106515
    Tebuquine 74129-03-6 98%
    Tebuquine (WR228258), a 4-aminoquinoline, is a potent antimalarial agent. Tebuquine is active against the Chloroquine (HY-17589A) sensitive HB3 strain and the Chloroquine resistant K1 strain of Plasmodium falciparum with IC50s of 0.9 nM and 20.8 nM, respectively.
    Tebuquine
  • HY-106546
    Tolciclate 50838-36-3 98%
    Tolciclate (KC 9147) is an antifungal agent with in vitro inhibitory activity against dermatophytes, effective at concentrations of 0.01-0.1 μg/mL. Tolciclate is colorless and soluble in well-tolerated excipients, and it is more lipophilic than Tolnaftate (HY-B0370). Tolciclate can be used in research related to antifungal infections.
    Tolciclate
  • HY-106572
    Cefbuperazone 76610-84-9 98%
    Cefbuperazone belongs to the cephalomycin-type compound.
    Cefbuperazone
  • HY-106575
    Nifurzide 39978-42-2 98%
    Nifurzide, a nitrofuran derivative, is used as an intestinal antiinfectious agent. Nifurzide shows strong bactericidal effect.
    Nifurzide
  • HY-106590
    Saccharocin 86630-31-1 98%
    Saccharocin (Antibiotic KA 5685) is effective against Gram-positive and negative bacteria, and also against aminoglycoside antibiotic-resistant bacteria.
    Saccharocin
  • HY-106655
    PGE 9262932 221221-18-7 98%
    PGE 9262932 is a quinolone antibacterial agent. PGE 9262932 can be used for the research of infection.
    PGE 9262932
  • HY-106705
    Apalcillin sodium 58795-03-2 98%
    Apalcillin (PC-904) (sodium) is an antibacterial agent. Apalcillin (sodium) is active against carbenicillin- and ampicillin-resistant strains of gram-negative bacilli.
    Apalcillin sodium
  • HY-106760
    FK 089 86070-74-8 98%
    FK 089 is an antibacterial Agent. FK 089 can be used for the research of infection.
    FK 089
  • HY-106773
    Norfloxacin succinil 100587-52-8 98%
    Norfloxacin succinil is a quinolone antibacterial agent. Norfloxacin succinil can be used in the research of infectious diseases such as urinary tract infections.
    Norfloxacin succinil
  • HY-106774
    R-61837 100241-46-1 98%
    R-61837 is a synthetic antirhinoviral compound with significant in vitro activity. R-61837 is 10 times and 57 times more active against human rhinovirus type 9 (HRV-9) than Enviroxime and dichloroflavone (DCF), respectively, and is more active against human rhinovirus type 2 (HRV-2 ) were 5 times and 10 times higher respectively.
    R-61837
  • HY-106791
    CGP 31608 107740-67-0 98%
    CGP 31608 is a semisynthetic penem derivative with antibacterial activity. CGP 31608 is resistant to many important beta-lactamases (including the mutationally derepressed chromosomal enzymes). CGP 31608 can be used for the research of infection.
    CGP 31608
  • HY-106923
    BMS-181184 139272-69-8 98%
    BMS-181184 is a new Pradimicin derivative and fungicide. BMS-181184 exhibits fungicidal activity against yeasts, dermatophytes, and most Aspergillus fumigatus strains. BMS-181184 is active against Sporothrix schenckii, dematiaceous fungi, and some members of the non-Aspergillus hyaline hyphomycetes.
    BMS-181184
  • HY-106940
    DV-7751A 151390-79-3 98%
    DV-7751A is a new Fluoroquinolone and antibacterial agent. DV-7751A inhibits the supercoiling activity of DNA gyrases. DV-7751A exhibits antimicrobial activity against Streptococcus pneumonae, Streptococcus pyogenes, and Peptostreptococcus spp. DV-7751A has a rapid bactericidal effect against S. aureus, Escherichia coli, and P. aeruginosa.
    DV-7751A
  • HY-106971
    PD 161374 177785-47-6 98%
    PD 161374 is an inhibitor targeting the HIV-1 nucleocapsid protein NCp7. PD 161374 primarily acts on the early stages of viral replication, inhibiting the completion of reverse transcription without affecting viral entry or later assembly. PD 161374 remains active against HIV-1, HIV-2, SIV, and drug-resistant strains. PD 161374 can be used to study antiretroviral agents.
    PD 161374
  • HY-106991
    Amustaline 878189-87-8 98%
    Amustaline (S-303) is a compound used for inactivating pathogens in blood components and belongs to the category of nucleic acid-targeted chemical decontaminants. Amustaline has the ability to inactivate viruses and is effective against mosquito-borne viruses such as Chikungunya virus (CHIKV), Dengue virus (DENV), and Zika virus (ZIKV). When combined with glutathione (Glutathione, GSH), which acts as a neutralizer to counteract adverse reactions, Amustaline ensures the stability of red blood cell membranes. Amustaline is mainly used for inactivating pathogens in red blood cell concentrates (RBCC) to reduce the risk of transfusion-transmitted infections (TTI).
    Amustaline
  • HY-107001
    DPC 961 214287-88-4 98%
    DPC 961 (DMP 961) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). DPC 961 is a potent and specific inhibitor of HIV-1 reverse transcriptase, which inhibits the activity of HIV-1 reverse transcriptase in a non-competitive manner, thereby preventing viral replication. DPC 961 can be used for research on AIDS.
    DPC 961
  • HY-107003
    Opaviraline 178040-94-3 98%
    Opaviraline (GW420867X) is an anti-HIV-1 reverse transcriptase inhibitor.
    Opaviraline
Cat. No. Product Name / Synonyms Application Reactivity